Skip to content

Efficacy of a Single dose versus Triple Dose Regimen of Mebendazole against Hookworm infections among School Children: Randomized trial.

Efficacy of a Single dose versus Triple Dose Regimen of Mebendazole against Hookworm infection among School Children: Randomized trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201911466695052
Enrollment
108
Registered
2019-11-29
Start date
2019-04-22
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hookworm infection

Interventions

mebendazole drug

Sponsors

University of Gondar
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Written informed consent signed by parents and/or legal guardians; and a verbal assent (children <18 years) according to Ethiopian regulation. • Able and willing to be examined by a study physician at the beginning of the study. • Able and willing to provide required stool samples at the beginning (baseline) and two to three weeks after treatment (follow-up). • Positive for hookworm eggs in the stool. • No recent anthelminthic treatment (within past 4 weeks). • Negative pregnancy test (girls =12 years) • Apparently health individual; based on medical history, physical examination, vital signs, hemoglobin level were included • Children who were able to chew the drug were subjected for randomization • Participant had hemoglobin level above 8g/dl

Exclusion criteria

Exclusion criteria: • Individual who has taken any form of medication containing mebendazole or any other treatment for STH infection within 30 days of entry into the study • Who had diarrhea at the time of the first sampling, • Who experience a severe concurrent medical condition, • Participant with haemoglobin level below 8g/dl, • Child with known history of allergic reaction to mebendazole, and • Participants infected with other parasitic infection were excluded from the allocated treatment

Design outcomes

Primary

MeasureTime frame
Cure rate or CR. CR means the proportion of individual hosts positive for parasites who become parasitologically negative after treatment

Secondary

MeasureTime frame
Arithmetic mean of Feacal Egg Reduction Rate OR ERR. ERR is the arithmetic mean egg count at baseline of the treatment group minus mean egg count at the end of treatment period divided by the mean egg count at the baseline and express it in percent.

Countries

Ethiopia

Contacts

Public ContactMulugeta Aemero

Department head of tropical and infectious diseases University of Gondar

bmeskel@gmail.com+25113073815

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026